Andrew P Grigg Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

7/2003

Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew P Grigg Research Topics

Disease

7	Neoplasms (Cancer) 10/2022 - 02/2002
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 11/2011
3	Thrombosis (Thrombus) 07/2019 - 07/2005
2	Residual Neoplasm 10/2022 - 07/2013
2	Vascular System Injuries 07/2019 - 09/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2010 - 02/2002
2	Infections 05/2005 - 11/2004
1	Hodgkin Disease (Hodgkin's Disease) 10/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022
1	Tumor Lysis Syndrome 10/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2021
1	Necrosis 07/2019
1	Leukemia 12/2018
1	Peripheral Arterial Occlusive Disease 1 09/2016
1	Carotid Artery Injuries 09/2016
1	Melanoma (Melanoma, Malignant) 12/2015
1	Hematologic Neoplasms (Hematological Malignancy) 12/2015
1	Fatigue 04/2010
1	Hemorrhage 07/2005
1	Venous Thromboembolism 07/2005
1	Primary Myelofibrosis (Myelosclerosis) 07/2005
1	Essential Thrombocythemia 07/2005
1	Diarrhea 01/2004
1	Bacteremia 01/2004
1	Septic Shock (Toxic Shock Syndrome) 01/2004
1	Fever (Fevers) 01/2004
1	Abdominal Pain (Pain, Abdominal) 01/2004
1	Neutropenia 01/2004
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2003
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2002

Drug/Important Bio-Agent (IBA)

5	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 11/2011
4	fludarabineIBA 05/2005 - 02/2002
3	Dasatinib (BMS 354825)FDA Link 07/2019 - 11/2011
3	InterferonsIBA 07/2019 - 04/2010
2	venetoclaxIBA 10/2022 - 01/2022
2	nilotinib FDA Link 07/2019 - 09/2016
2	Melphalan (Alkeran)FDA LinkGeneric 04/2010 - 07/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2005 - 11/2004
1	Brentuximab VedotinIBA 10/2023
1	CreatinineIBA 10/2022
1	ibrutinibIBA 10/2022
1	AzolesIBA 01/2022
1	ponatinibIBA 07/2019
1	P-SelectinIBA 07/2019
1	CollagenIBA 07/2019
1	Interleukin-6 (Interleukin 6)IBA 07/2019
1	Thromboxane B2IBA 07/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	Collagen Type I (Type I Collagen)IBA 09/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2015
1	Busulfan (Busulfex)FDA Link 04/2010
1	Interferon-alpha (Interferon Alfa)IBA 04/2010
1	AnthracyclinesIBA 04/2010
1	anagrelide (Agrylin)FDA LinkGeneric 07/2005
1	Hydroxyurea (Hydrea)FDA LinkGeneric 07/2005
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2005
1	Rituximab (Mabthera)FDA Link 05/2005
1	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2004
1	Anti-Infective Agents (Microbicides)IBA 01/2004
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2004
1	NucleosidesIBA 02/2002
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2002
1	DNA AdductsIBA 02/2002
1	Cisplatin (Platino)FDA LinkGeneric 02/2002
1	PlatinumIBA 02/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2004
2	Drug Therapy (Chemotherapy) 10/2023 - 04/2010
1	Combination Drug Therapy (Combination Chemotherapy) 11/2004
1	Hematopoietic Stem Cell Transplantation 07/2003
1	Stem Cell Transplantation 07/2003
1	Salvage Therapy 02/2002